BeStock  
Stocks › Biotechnology › AVTX

Avalo Therapeutics AVTX

US equityMarket cap rank #3681Biotechnology
$6.76 +$0.01 (+0.15%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.76 0.00%
Open$6.65
Prev close$6.75
Day range$6.61 – $7.03
Volume1.18M
Market cap$390.88M
P/E (TTM)–
Dividend yield–

AVTX Stock News

Headlines matching Avalo Therapeutics or the AVTX ticker, most recent first.

  • Guggenheim Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Cuts Target Price to $48 NegativeMarket news · 7 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Avalo Therapeutics(AVTX.US), With a Forecast Between $30 to $58Market news · 7 Aug 2026 · Direct mention
  • Leerink Partners Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $38Market news · 6 Jul 2026 · Direct mention
  • BofA Securities Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $35Market news · 12 Jun 2026 · Direct mention
  • TD Cowen Maintains Avalo Therapeutics(AVTX.US) With Buy RatingMarket news · 11 Jun 2026 · Direct mention
  • Stifel Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $36Market news · 7 May 2026 · Direct mention
  • Guggenheim Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $50Market news · 7 May 2026 · Direct mention
  • BTIG Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Raises Target Price to $58 PositiveMarket news · 6 May 2026 · Direct mention
  • Citizens JMP Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Raises Target Price to $62 PositiveMarket news · 6 May 2026 · Direct mention
  • BTIG Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $58Market news · 6 May 2026 · Direct mention
  • A Quick Look at Today's Ratings for Avalo Therapeutics(AVTX.US), With a Forecast Between $34 to $55Market news · 15 May 2026 · Direct mention
  • A Quick Look at Today's Ratings for Avalo Therapeutics(AVTX.US), With a Forecast Between $34 to $58Market news · 14 May 2026 · Direct mention
  • Piper Sandler Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Raises Target Price to $60 PositiveMarket news · 11 May 2026 · Direct mention
  • Wolfe Research Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $48Market news · 9 Apr 2026 · Direct mention
  • Citizens JMP Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $52Market news · 6 Apr 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on AVTX.

Sign in to join the discussion.

Scroll to Top